Related references
Note: Only part of the references are listed.A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy
Anita L. Grubb et al.
DIABETES CARE (2019)
Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank
Nicholas J. Thomas et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia
Suzy V. Hope et al.
DIABETOLOGIA (2018)
A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults
Richard A. Oram et al.
DIABETES CARE (2016)
Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic
S. V. Hope et al.
DIABETIC MEDICINE (2016)
Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes
Georgina M. Williams et al.
DIABETOLOGIA (2016)
Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature
Beverley M. Shields et al.
BMJ OPEN (2015)
The clinical utility of C-peptide measurement in the care of patients with diabetes
A. G. Jones et al.
DIABETIC MEDICINE (2013)
Clinical Applications of Diabetes Antibody Testing
Polly J. Bingley
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult) - Definition, characterization and potential prevention
P Pozzilli et al.
DIABETES CARE (2001)
Share Paper
